Areca-arecoline ester derivative as well as preparation method and application thereof

The arecaline ester derivatives developed by structural modification of arecaline have solved the problem of insufficient activity in the prior art, significantly enhanced the inhibitory effect on a variety of plant pathogenic fungi and pests, and achieved a variety of agricultural dosage forms. Preparation improves the prevention and control ability of pesticides.

CN118955359AActive Publication Date: 2024-11-15HAINAN UNIV

Patent Information

Application Number
CN202411035026.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-31
Publication Date
2024-11-15
Estimated Expiration
2044-07-31

AI Technical Summary

Technical Problem

In the prior art, arecaine has limited inhibitory activity on some plant pathogenic microorganisms and pests, and it is difficult to meet the effective prevention and control needs of pesticides for a variety of pathogenic bacteria and pests.

Method used

A arecacia ester derivative has been developed, whose structure has been modified by specific substituents, which significantly enhances its inhibitory activity against a variety of plant pathogenic fungi and pests, and forms bactericidal and insecticidal through specific preparation methods and application forms. Composition.

Benefits of technology

Arecaline ester derivatives show significant inhibition and killing effects on a variety of plant pathogenic fungi and pests, including rice trench blight, apple trench blight, etc., and their preparation methods can be used to form a variety of agricultural dosage forms to improve the The efficiency of pesticide use.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The invention discloses an arecoline ester derivative as well as a preparation method and application thereof, and relates to the technical field of chemical pesticides, the arecoline ester derivative provided by the invention has a brand new molecular structure, and the bacteriostatic activity and insecticidal activity of the arecoline ester derivative are remarkably enhanced compared with that of arecoline; the compound has a certain inhibition effect on pyricularia, mango stem-end rot pathogen, wheat scab pathogen, rhizoctonia solani, phomopsis, apple ring spot pathogen, tea pestalotiopsis, mango anthracnose pathogen and phytophthora capsici pathogen; meanwhile, the compound shows certain insecticidal activity on aedes aegypti larvae.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of chemical pesticides, and in particular to an arecoline ester derivative and a preparation method and application thereof. Background Art

[0002] Using natural products as lead compounds for structural modification and derivatization is the main strategy for the development of new pesticides at this stage. Plant-derived natural products are easy to degrade in nature, have low toxicity to crops, and have low residues, which is in line with the current development trend of green pesticides.

[0003] Arecoline is the main active substance in the palm plant Areca catechu, which has a certain paralytic effect on the nervous system, and thus exhibits certain agricultural insecticide activity. It also has the ability to resist pathogenic microorganisms. Existing studies have shown that arecoline has a certain anti-tapeworm ( Dipylidium caninum )、Oncomelania Oncomelania hupensis Gredler and blowflies ( Calliphora vicinal ) maggots have a certain activity against the third instar larvae of the diamondback moth LC 50 is 64.62 mg / L. At the same time, arecoline has an inhibitory effect on Staphylococcus aureus ( Staphylococcus aureus )、Bacillus subtilis( Bacillus subtle ), Bacillus cereus ( Bacillus cereus ), Escherichia coli ( Escherichia coli ) all had inhibitory effects, with the minimum inhibitory concentrations against Staphylococcus aureus and Bacillus subtilis being 12.50 and 6.25 mg / mL, respectively. Summary of the invention

[0004] In view of the above technical problems in the related art, the present invention provides an arecoline ester derivative and a preparation method and application thereof, which can solve the above problems.

[0005] To achieve the above technical objectives, the technical solution of the present invention is implemented as follows: An arecoline ester derivative, the structural formula of which is shown in formula (I): In formula (I): X is selected from S or O; m is 0, 1, 2 or 3; R is selected from R 1 is an aromatic ring containing a substituent, R 2 is an alicyclic ring containing a substituent, R 3 is an oxygen heterocycle containing a substituent, R 4 is a nitrogen heterocyclic ring containing a substituent, R 5 is a sulfur heterocycle containing a substituent, R 6 is a substituted aromatic heterocyclic ring, R7 is a benzoheterocyclic ring containing a substituent, R 8 It is a polycyclic aromatic hydrocarbon containing substituents.

[0006] Furthermore, in formula (I), R is selected from R 1 N 1 Substituted aromatic ring, R 2 N 2 Substituted alicyclic, R 3 N 3 Substituted oxygen heterocycle, R 4 N 4 Substituted nitrogen heterocycle, R 5 N 5 Substituted sulfur heterocycle, R 6 N 6 Substituted aromatic heterocycle, R 7 N 7 Substituted benzoheterocycle, R 8 N 8 Substituted polycyclic aromatic hydrocarbons.

[0007] Furthermore, N 1 One or more selected from the group consisting of a hydrogen atom, a halogen atom, a cyano group, an amino group, a hydroxyl group, a C1-C6 alkyl group, a halogenated C1-C6 alkyl group, a C1-C6 alkoxy group, a halogenated C1-C6 alkoxy group, a C1-C6 alkylamino group, a halogenated C1-C6 alkylamino group, a di(C1-C6 alkyl)amino group, a halogenated di(C1-C6 alkyl)amino group, a C1-C6 alkoxycarbonyl group, a halogenated C1-C6 alkoxycarbonyl group, a C1-C6 alkylaminocarbonyl group, a halogenated C1-C6 alkylaminocarbonyl group, a di(C1-C6 alkyl)aminocarbonyl group, a halogenated di(C1-C6 alkyl)aminocarbonyl group, a C1-C6 alkylsulfonyl group, a halogenated C1-C6 alkylsulfonyl group, a di(C1-C6 alkyl)aminosulfonyl group, a halogenated di(C1-C6 alkyl)aminosulfonyl group, a C1-C6 alkylsulfonyloxy group, and a halogenated C1-C6 alkylsulfonyloxy group; N 2 One or more selected from the group consisting of a hydrogen atom, a halogen atom, a cyano group, an amino group, a hydroxyl group, a C1-C6 alkyl group, a halogenated C1-C6 alkyl group, a C3-C6 cycloalkyl group, a halogenated C3-C6 cycloalkyl group, a C2-C6 alkenyl group, a halogenated C2-C6 alkenyl group, a C2-C6 alkenyloxy group, a halogenated C2-C6 alkenyloxy group, a C1-C6 alkoxy group, a halogenated C1-C6 alkoxy group, a C1-C6 alkylamino group, a halogenated C1-C6 alkylamino group, a di(C1-C6 alkyl)amino group, a halogenated di(C1-C6 alkyl)amino group, a C1-C6 alkoxycarbonyl group, a halogenated C1-C6 alkoxycarbonyl group, a C1-C6 alkylaminocarbonyl group, a halogenated C1-C6 alkylaminocarbonyl group, a di(C1-C6 alkyl)aminocarbonyl group, and a halogenated di(C1-C6 alkyl)aminocarbonyl group; N 3One or more selected from the group consisting of a hydrogen atom, a halogen atom, a cyano group, an amino group, a hydroxyl group, a C1-C6 alkyl group, a halogenated C1-C6 alkyl group, a C1-C6 alkoxy group, a halogenated C1-C6 alkoxy group, a C1-C6 alkylamino group, a halogenated C1-C6 alkylamino group, a di(C1-C6 alkyl)amino group, a halogenated di(C1-C6 alkyl)amino group, a C1-C6 alkoxycarbonyl group, a halogenated C1-C6 alkoxycarbonyl group, a C1-C6 alkylaminocarbonyl group, a halogenated C1-C6 alkylaminocarbonyl group, a di(C1-C6 alkyl)aminocarbonyl group, and a halogenated di(C1-C6 alkyl)aminocarbonyl group; N 4 One or more selected from the group consisting of a hydrogen atom, a halogen atom, a cyano group, an amino group, a hydroxyl group, a C1-C6 alkyl group, a halogenated C1-C6 alkyl group, a C1-C6 alkoxy group, a halogenated C1-C6 alkoxy group, a C1-C6 alkylamino group, a halogenated C1-C6 alkylamino group, a di(C1-C6 alkyl)amino group, a halogenated di(C1-C6 alkyl)amino group, a C1-C6 alkoxycarbonyl group, a halogenated C1-C6 alkoxycarbonyl group, a C1-C6 alkylaminocarbonyl group, a halogenated C1-C6 alkylaminocarbonyl group, a di(C1-C6 alkyl)aminocarbonyl group, and a halogenated di(C1-C6 alkyl)aminocarbonyl group; N 5 One or more selected from hydrogen atom, halogen atom, cyano group, amino group, hydroxyl group, C1-C6 alkyl group, halogenated C1-C6 alkyl group, C1-C6 alkoxy group, halogenated C1-C6 alkoxy group, C1-C6 alkylamino group, halogenated C1-C6 alkylamino group, di(C1-C6 alkyl)amino group, halogenated di(C1-C6 alkyl)amino group, C1-C6 alkoxycarbonyl group, halogenated C1-C6 alkoxycarbonyl group, C1-C6 alkylaminocarbonyl group, halogenated C1-C6 alkylaminocarbonyl group, di(C1-C6 alkyl)aminocarbonyl group, halogenated di(C1-C6 alkyl)aminocarbonyl group, C1-C6 alkylthio group, halogenated C1-C6 alkylthio group, C1-C6 alkenylthio group and halogenated C1-C6 alkenylthio group; N 6 One or more selected from the group consisting of a hydrogen atom, a halogen atom, a cyano group, an amino group, a hydroxyl group, a C1-C6 alkyl group, a halogenated C1-C6 alkyl group, a C1-C6 alkoxy group, a halogenated C1-C6 alkoxy group, a C1-C6 alkylamino group, a halogenated C1-C6 alkylamino group, a di(C1-C6 alkyl)amino group, a halogenated di(C1-C6 alkyl)amino group, a C1-C6 alkoxycarbonyl group, a halogenated C1-C6 alkoxycarbonyl group, a C1-C6 alkylaminocarbonyl group, a halogenated C1-C6 alkylaminocarbonyl group, a di(C1-C6 alkyl)aminocarbonyl group, and a halogenated di(C1-C6 alkyl)aminocarbonyl group; N 7One or more selected from the group consisting of a hydrogen atom, a halogen atom, a cyano group, an amino group, a hydroxyl group, a C1-C6 alkyl group, a halogenated C1-C6 alkyl group, a C1-C6 alkoxy group, a halogenated C1-C6 alkoxy group, a C1-C6 alkylamino group, a halogenated C1-C6 alkylamino group, a di(C1-C6 alkyl)amino group, a halogenated di(C1-C6 alkyl)amino group, a C1-C6 alkoxycarbonyl group, a halogenated C1-C6 alkoxycarbonyl group, a C1-C6 alkylaminocarbonyl group, a halogenated C1-C6 alkylaminocarbonyl group, a di(C1-C6 alkyl)aminocarbonyl group, and a halogenated di(C1-C6 alkyl)aminocarbonyl group; N 8 One or more selected from a hydrogen atom, a halogen atom, a cyano group, an amino group, a hydroxyl group, a C1-C6 alkyl group, a halogenated C1-C6 alkyl group, a C1-C6 alkoxy group, a halogenated C1-C6 alkoxy group, a C1-C6 alkylamino group, a halogenated C1-C6 alkylamino group, a di(C1-C6 alkyl)amino group, a halogenated di(C1-C6 alkyl)amino group, a C1-C6 alkoxycarbonyl group, a halogenated C1-C6 alkoxycarbonyl group, a C1-C6 alkylaminocarbonyl group, a halogenated C1-C6 alkylaminocarbonyl group, a di(C1-C6 alkyl)aminocarbonyl group and a halogenated di(C1-C6 alkyl)aminocarbonyl group.

[0008] A method for preparing arecoline ester derivatives, The compounds represented by general formula II, III and IV are reacted to obtain the product. The specific reaction steps include: S1. Put the compound of formula II and thionyl chloride into a round-bottom flask under anhydrous conditions, reflux until the solid is completely dissolved, remove the excess thionyl chloride to obtain a white solid compound of formula III, and directly proceed to the next step without purification; S2. React the compound of formula III, an acid-binding agent, a compound of formula IV and an organic solvent at -5 to 50°C and monitor the reaction by TLC. After the reaction is completed, extract, concentrate and purify by silica gel column chromatography to obtain a compound of formula I.

[0009] Furthermore, the acid binding agent is one or more of triethylamine, pyridine, N,N-diisopropylethylamine, 1-methylpyridine, sodium acetate, potassium carbonate, and sodium hydroxide; the organic solvent is one or more of dichloromethane, chloroform, carbon tetrachloride, ethyl acetate, acetonitrile, N,N-dimethylformamide, dimethyl sulfoxide, methanol, ethanol, petroleum ether, n-butanol, benzene, toluene, xylene, ether, and tetrahydrofuran.

[0010] The invention discloses an application of arecoline ester derivatives, wherein the arecoline ester derivatives are applied to a bactericidal composition and an insecticidal composition.

[0011] Furthermore, the fungicide composition includes at least one of the arecoline ester derivatives and is used as an agricultural fungicide. The mass fraction of the arecoline ester derivative in the fungicide composition is 1 to 99.9%.

[0012] Furthermore, the formulation of the agricultural fungicide is at least one of emulsifiable concentrate, water emulsion, microemulsion, wettable powder, water dispersible granules, and suspension, and the agricultural fungicide is used to control plant pathogenic fungi, and the plant pathogenic fungi include: Oomycetes, such as Peronosporales, White rust ( White )、Syndrome stagnation pathogen ( Pythium )、cotton rot bacteria( Achlya )、Phytophthora Phytophthora )、late blight fungus( Phytophthora ); Basidiomycotina, such as Uredinales and Ustilaginales; Ascomycotina, such as Erysiphales and Black Spot; Ceratocystis ),anthrax( Glomerulus )、Fusarium fusiformis( Gibberella )、Ergot fungus( Harpsichord )、Sclerotinia sclerotiorum( Sclerotinia )、Black Vent Fungus( Ventura ), ; Deuteromycotina, such as brown rot fungus ( Necklaces )、Powdery mildew( Oedipus )、Pyricularia grisea( Firefly )、Penicillium spp.( Penicillium )、Verticillium dahliae( Verticillium wilt )、Brown spot pathogenic bacteria( Cercospora )、Ring rot bacteria( Alternaria )、Black mold fungus( Cladosporium )、Rhizoctonia solani( Rhizectomy )、Sclerotium rolfsii( Scarotium )、Fusarium fusiformis( Fusarium )、Anthrax ( Colletotrichum ) Pestalotiopsis )、Phomopsis sphaeroides( Phomopsis ), Diplodia, etc.

[0013] Further, the selected plant pathogenic fungi are one or more of Magnaporthe oryzae, Botryodipladiatheobromae, Fusarium verticillioides, Bothryosphaeriadothidea, Colletotrichum gloeosporioides, Rhizoctonia solani, Diaporthe ambigua, Pseudopestalotiopsis theae, and Phytophthora capsici.

[0014] Furthermore, the insecticide composition comprises at least one of the arecoline ester derivatives and is used as an agricultural insecticide. The mass fraction of the arecoline ester derivative in the insecticide composition is 1 to 99.9%.

[0015] Furthermore, the dosage form of the agricultural insecticide is at least one of emulsifiable concentrate, water emulsion, microemulsion, wettable powder, water dispersible granules, and suspension, and the agricultural insecticide is used to control pests or mites, and the pests or mites include: Lepidoptera, Homoptera, Thysanoptera, and Arachnoidea.

[0016] Further, the selected pest or mite is Aedes aegypti ( Aedes aegypti ) larvae, Plutella xylostella ( Small xylostella ) larvae of one or more species.

[0017] The invention has the beneficial effects that the arecoline ester derivatives provided by the invention have a brand-new molecular structure, and compared with arecoline, the antibacterial activity and insecticidal activity thereof are significantly enhanced; the derivatives have a certain inhibitory effect on blast fungi, mango stem rot fungi, wheat fusarium rust fungi, rice sheath blight fungi, phomopsis sphaeroides fungi, apple ring rot fungi, tea polytrichomonas, mango anthracnose fungi, and pepper phytophthora fungi; and at the same time, they exhibit a certain insecticidal activity against the larvae of Aedes aegypti. DETAILED DESCRIPTION

[0018] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. All other embodiments obtained by ordinary technicians in this field based on the embodiments of the present invention belong to the scope of protection of the present invention.

[0019] Embodiment 1: The structural formula of the arecoline ester derivatives of this embodiment is shown in Ⅰ-1 below: Its synthesis method is: Step 1: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid (arecaline) Dissolve 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid methyl ester-hydrobromide (arecoline hydrobromide) (2.35 g, 10 mmol) in water (30 mL) and adjust the pH value to 10-11 with 30% Na2CO3. Extract the mixed solution with CH2Cl2 (3×30 mL), combine the organic phases, wash with saturated brine, and dry over anhydrous magnesium sulfate. Filter and concentrate under reduced pressure to obtain a yellow oil, add water (30 mL) and reflux at high temperature for 24 h. After the reaction is completed, concentrate under reduced pressure, wash the crude product with anhydrous ethanol, and obtain white flaky crystals of arecoline with a yield of 86%.

[0020] Step 2: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carbonyl chloride Place arecaline (0.917 g, 6.5 mmol) in a dry two-necked flask, add SOCl2 (5 mL), and heat to reflux. The reaction ends when the solid is completely dissolved. Remove the excess SOCl2 under reduced pressure to obtain a powdery white solid, which can be directly used for the next step without purification.

[0021] Step 3: Preparation of Compound Ⅰ-1 The compound prepared in step 2 (0.24 g, 1.5 mmol) was placed in anhydrous CH2Cl2, and triethylamine (0.3 mL, 2 mmol) and 3,5-dichlorothiophenol (0.269 g, 1.5 mmol) were added in turn under an ice bath, and the mixture was reacted at room temperature for 0.5 h. After the reaction was completed, saturated NaHCO3 was added to quench the reaction, and the mixture was extracted with CH2Cl2 (3×20 mL), the organic phases were combined, washed with saturated brine, dried over anhydrous MgSO4, filtered, concentrated under reduced pressure, and purified by silica gel column chromatography (eluent: petroleum ether: ethyl acetate = 4:1) to obtain a yellow oily liquid with a yield of 67.5%.

[0022] The results of H NMR spectrum are: 1 H NMR (400 MHz, Chloroform- d ) δ 7.40 (t, J = 1.9 Hz, 1H),7.33 (d, J= 1.9 Hz, 2H), 7.18 – 7.10 (m, 1H), 3.22 – 3.16 (m, 2H), 2.55 (m,2H), 2.51 – 2.43 (m, 2H), 2.41 (s,3H).

[0023] Embodiment 2: The structural formula of the arecoline ester derivatives of this embodiment is shown in I-12 below: Its synthesis method is: Step 1: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid (arecaline) Dissolve 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid methyl ester-hydrobromide (arecoline hydrobromide) (2.35g, 10mmol) in water (30 mL) and adjust the pH value to 10-11 with 30% Na2CO3. Extract the mixed solution with CH2Cl2 (3×30 mL), combine the organic phases, wash with saturated brine, and dry over anhydrous magnesium sulfate. Filter and concentrate under reduced pressure to obtain a yellow oil, add water (30 mL) and reflux at high temperature for 24h. After the reaction is completed, concentrate under reduced pressure, wash the crude product with anhydrous ethanol, and obtain white flaky crystals of arecoline with a yield of 86%.

[0024] Step 2: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carbonyl chloride Arecaline (0.917 g, 6.5 mmol) was placed in a dry two-necked flask, SOCl2 (5 mL) was added, and the temperature was raised to reflux. The reaction was completed when the solid was completely dissolved. The excess SOCl2 was removed under reduced pressure to obtain a powdery white solid, which was directly used for the next step without purification.

[0025] Step 3: Preparation of Compound Ⅰ-12 The compound prepared in step 2 (0.24 g, 1.5 mmol) was placed in anhydrous CH2Cl2, and triethylamine (0.3 mL, 2 mmol) and 4-methylthiothiophene-2-thiol (0.245 g, 1.5 mmol) were added in turn under an ice bath, and the mixture was reacted at room temperature for 0.5 h. After the reaction was completed, saturated NaHCO3 was added to quench the reaction, and the mixed solution was extracted with CH2Cl2 (3×20 mL), the organic phases were combined, washed with saturated brine, dried over anhydrous MgSO4, filtered, concentrated under reduced pressure, and purified by silica gel column chromatography (eluent: petroleum ether: ethyl acetate = 4:1) to obtain a yellow oily liquid with a yield of 60.1%.

[0026] The results of H NMR spectrum are: 1H NMR (400 MHz, Chloroform- d ) δ 7.22 – 7.14 (m, 1H),7.12 – 7.03 (m, 1H), 6.87 – 6.60 (m, 1H), 3.86 – 3.47 (m, 2H), 2.85 – 2.78(m, 2H),2.47 (s, 2H), 2.31 (s, 3H), 2.29 – 2.13 (m, 2H).

[0027] Embodiment three: The structural formula of the arecoline ester derivatives of this embodiment is shown in I-25 below: Its synthesis method is: Step 1: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid (arecaline) Dissolve 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid methyl ester-hydrobromide (arecoline hydrobromide) (2.35g, 10mmol) in water (30 mL) and adjust the pH value to 10-11 with 30% Na2CO3. Extract the mixed solution with CH2Cl2 (3×30 mL), combine the organic phases, wash with saturated brine, and dry over anhydrous magnesium sulfate. Filter and concentrate under reduced pressure to obtain a yellow oil, add water (30 mL) and reflux at high temperature for 24 h. After the reaction is completed, concentrate under reduced pressure, wash the crude product with anhydrous ethanol, and obtain white flaky crystals of arecoline with a yield of 86%.

[0028] Step 2: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carbonyl chloride Place arecaline (0.917 g, 6.5 mmol) in a dry two-necked flask, add SOCl2 (5 mL), and heat to reflux. The reaction ends when the solid is completely dissolved. Remove the excess SOCl2 under reduced pressure to obtain a powdery white solid, which can be directly used for the next step without purification.

[0029] Step 3: Preparation of Compound Ⅰ-25 The compound prepared in step 2 (0.24 g, 1.5 mmol) was placed in anhydrous CH2Cl2, and triethylamine (0.3 mL, 2 mmol) and 2-methylthiol-5-trifluoromethylpyridine (0.269 g, 1.5 mmol) were added in turn under an ice bath, and the mixture was reacted at room temperature for 0.5 h. After the reaction was completed, saturated NaHCO3 was added to quench the reaction, and the mixed solution was extracted with CH2Cl2 (3×20 mL), the organic phases were combined, washed with saturated brine, dried over anhydrous MgSO4, filtered, concentrated under reduced pressure, and purified by silica gel column chromatography (eluent: petroleum ether: ethyl acetate = 4:1) to obtain a yellow solid with a yield of 58.9%.

[0030] The results of H NMR spectrum are: 1 H NMR (400 MHz, Chloroform- d ) δ 8.53 (d, J = 1.9 Hz, 1H),7.55 – 7.50 (m, 1H), 7.37 (d, J = 6.4 Hz, 1H), 6.78 – 6.72 (m, 1H), 4.37 (s,1H), 3.22 – 3.16 (m, 2H), 2.85 – 2.78 (m, 2H), 2.31 (s, 3H), 2.28 – 2.14 (m,2H).

[0031] Embodiment 4: The structural formula of the arecoline ester derivatives of this embodiment is shown in I-29 below: Its synthesis method is: Step 1: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid (arecaline) Dissolve 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid methyl ester-hydrobromide (arecoline hydrobromide) (2.35g, 10mmol) in water (30 mL) and adjust the pH value to 10-11 with 30% Na2CO3. Extract the mixed solution with CH2Cl2 (3×30 mL), combine the organic phases, wash with saturated brine, and dry over anhydrous magnesium sulfate. Filter and concentrate under reduced pressure to obtain a yellow oil, add water (30 mL) and reflux at high temperature for 24h. After the reaction is completed, concentrate under reduced pressure, wash the crude product with anhydrous ethanol, and obtain white flaky crystals of arecoline with a yield of 86%.

[0032] Step 2: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carbonyl chloride Place arecaline (0.917 g, 6.5 mmol) in a dry two-necked flask, add SOCl2 (5 mL), and heat to reflux. The reaction ends when the solid is completely dissolved. Remove the excess SOCl2 under reduced pressure to obtain a powdery white solid, which can be directly used for the next step without purification.

[0033] Step 3: Preparation of Compound Ⅰ-29 The compound prepared in step 2 (0.24 g, 1.5 mmol) was placed in anhydrous CH2Cl2, and triethylamine (0.3 mL, 2 mmol) and 7-fluoro-4-methylthiolquinazoline (0.293 g, 1.5 mmol) were added in turn under an ice bath, and the mixture was reacted at room temperature for 0.5 h. After the reaction was completed, saturated NaHCO3 was added to quench the reaction, and the mixed solution was extracted with CH2Cl2 (3×20 mL), the organic phases were combined, washed with saturated brine, dried over anhydrous MgSO4, filtered, concentrated under reduced pressure, and purified by silica gel column chromatography (eluent: petroleum ether: ethyl acetate = 4:1) to obtain a yellow oily liquid with a yield of 55.2%.

[0034] The results of H NMR spectrum are: 1 H NMR (400 MHz, Chloroform- d ) δ 9.19 (s, 1H), 8.12 –8.05 (m, 1H), 7.46 – 7.40 (m, 1H), 7.18 – 7.10 (m, 1H),6.78 – 6.72 (m, 1H),4.61 (s, 2H), 3.22 – 3.16 (m, 2H), 2.85 – 2.78 (m, 2H), 2.31 (s, 3H), 2.28 –2.14 (m, 2H).

[0035] Embodiment five: The structural formula of the arecoline ester derivatives of this embodiment is shown in I-38 below: Its synthesis method is: Step 1: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid (arecaline) Dissolve 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid methyl ester-hydrobromide (arecoline hydrobromide) (2.35 g, 10 mmol) in water (30 mL) and adjust the pH value to 10-11 with 30% Na2CO3. Extract the mixed solution with CH2Cl2 (3×30 mL), combine the organic phases, wash with saturated brine, and dry over anhydrous magnesium sulfate. Filter and concentrate under reduced pressure to obtain a yellow oil, add water (30 mL) and reflux at high temperature for 24 h. After the reaction is completed, concentrate under reduced pressure, wash the crude product with anhydrous ethanol, and obtain white flaky crystals of arecoline with a yield of 86%.

[0036] Step 2: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carbonyl chloride Place arecaline (0.917 g, 6.5 mmol) in a dry two-necked flask, add SOCl2 (5 mL), and heat to reflux. The reaction ends when the solid is completely dissolved. Remove the excess SOCl2 under reduced pressure to obtain a powdery white solid, which can be directly used for the next step without purification.

[0037] Step 3: Preparation of Compound I-38 The compound prepared in step 2 (0.24 g, 1.5 mmol) was placed in anhydrous CH2Cl2, and triethylamine (0.3 mL, 2 mmol) and 4-methylmercaptoquinazoline (0.264 g, 1.5 mmol) were added in turn under an ice bath, and the mixture was reacted at room temperature for 0.5 h. After the reaction was completed, saturated NaHCO3 was added to quench the reaction, and the mixed solution was extracted with CH2Cl2 (3×20 mL), the organic phases were combined, washed with saturated brine, dried over anhydrous MgSO4, filtered, concentrated under reduced pressure, and purified by silica gel column chromatography (eluent: petroleum ether: ethyl acetate = 4:1) to obtain a yellow oily liquid with a yield of 69.1%.

[0038] The results of H NMR spectrum are: 1 H NMR (400 MHz, Chloroform- d ) δ 8.60 (d, J = 1.8 Hz, 1H),7.39 (d, J = 1.6 Hz, 1H), 6.78 – 6.72 (m, 1H), 3.38 – 3.32 (m, 2H), 3.22 – 3.16(m, 2H), 3.14 – 3.08 (m, 2H), 2.85 – 2.78 (m, 2H), 2.28 – 2.14 (m, 2H).

[0039] Embodiment six: The structural formula of the arecoline ester derivatives of this embodiment is shown in I-59 below: Its synthesis method is: Step 1: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid (arecaline) Dissolve 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid methyl ester-hydrobromide (arecoline hydrobromide) (2.35 g, 10 mmol) in water (30 mL) and adjust the pH value to 10-11 with 30% Na2CO3. Extract the mixed solution with CH2Cl2 (3×30 mL), combine the organic phases, wash with saturated brine, and dry over anhydrous magnesium sulfate. Filter and concentrate under reduced pressure to obtain a yellow oil, add water (30 mL) and reflux at high temperature for 24 h. After the reaction is completed, concentrate under reduced pressure, wash the crude product with anhydrous ethanol, and obtain white flaky crystals of arecoline with a yield of 86%.

[0040] Step 2: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carbonyl chloride Place arecaline (0.917 g, 6.5 mmol) in a dry two-necked flask, add SOCl2 (5 mL), and heat to reflux. The reaction ends when the solid is completely dissolved. Remove the excess SOCl2 under reduced pressure to obtain a powdery white solid, which can be directly used for the next step without purification.

[0041] Step 3: Preparation of Compound Ⅰ-59 The compound prepared in step 2 (0.24 g, 1.5 mmol) was placed in anhydrous CH2Cl2, and triethylamine (0.3 mL, 2 mmol) and 3-methylnaphthalene-2-ol (0.239 g, 1.5 mmol) were added in turn under ice bath, and the mixture was reacted at room temperature for 0.5 h. After the reaction was completed, saturated NaHCO3 was added to quench the reaction, and the mixed solution was extracted with CH2Cl2 (3×20 mL), the organic phases were combined, washed with saturated brine, dried over anhydrous MgSO4, filtered, concentrated under reduced pressure, and purified by silica gel column chromatography (eluent: ethyl acetate) to obtain a yellow oily liquid with a yield of 69.7%.

[0042] The results of H NMR spectrum are: 1 H NMR (400 MHz, Chloroform- d ) δ7.77 – 7.67 (m, 2H),7.65 – 7.61 (m, 1H), 7.50 – 7.42 (m, 3H), 6.73 – 6.68 (m, 1H), 3.22 – 3.16(m, 2H), 2.84 –2.75 (m, 2H), 2.32 (s, 3H), 2.31 (s, 3H), 2.29 – 2.16 (m, 2H).

[0043] Embodiment seven: The structural formula of the arecoline ester derivatives of this embodiment is shown in I-61 below: Its synthesis method is: Step 1: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid (arecaline) Dissolve 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid methyl ester-hydrobromide (arecoline hydrobromide) (2.35 g, 10 mmol) in water (30 mL) and adjust the pH value to 10-11 with 30% Na2CO3. Extract the mixed solution with CH2Cl2 (3×30 mL), combine the organic phases, wash with saturated brine, and dry over anhydrous magnesium sulfate. Filter and concentrate under reduced pressure to obtain a yellow oil, add water (30 mL) and reflux at high temperature for 24 h. After the reaction is completed, concentrate under reduced pressure, wash the crude product with anhydrous ethanol, and obtain white flaky crystals of arecoline with a yield of 86%.

[0044] Step 2: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carbonyl chloride Arecaline (0.917 g, 6.5 mmol) was placed in a dry two-necked flask, SOCl2 (5 mL) was added, and the temperature was raised to reflux. The reaction was completed when the solid was completely dissolved. The excess SOCl2 was removed under reduced pressure to obtain a powdery white solid, which was directly used for the next step without purification.

[0045] Step 3: Preparation of Compound Ⅰ-61 The compound prepared in step 2 (0.24 g, 1.5 mmol) was placed in anhydrous CH2Cl2, and triethylamine (0.3 mL, 2 mmol) and 5-cyano-2-hydroxypyrimidine (0.186 g, 1.5 mmol) were added in turn under an ice bath, and the mixture was reacted at room temperature for 0.5 h. After the reaction was completed, saturated NaHCO3 was added to quench the reaction, and the mixed solution was extracted with CH2Cl2 (3×20 mL), the organic phases were combined, washed with saturated brine, dried over anhydrous MgSO4, filtered, concentrated under reduced pressure, and purified by silica gel column chromatography (eluent: ethyl acetate) to obtain a yellow oily liquid with a yield of 71.1%.

[0046] The results of H NMR spectrum are: 1 H NMR (400 MHz, Chloroform- d ) δ 8.77 (s, 2H), 6.74 –6.68 (m, 1H), 3.73 – 3.51 (m, 2H), 2.84 – 2.75 (m, 2H), 2.31 (s, 3H), 2.29 –2.16 (m, 2H).

[0047] Embodiment eight: The structural formula of the arecoline ester derivatives of this embodiment is shown in I-65 below: Its synthesis method is: Step 1: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid (arecaline) Dissolve 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid methyl ester-hydrobromide (arecoline hydrobromide) (2.35 g, 10 mmol) in water (30 mL) and adjust the pH value to 10-11 with 30% Na2CO3. Extract the mixed solution with CH2Cl2 (3×30 mL), combine the organic phases, wash with saturated brine, and dry over anhydrous magnesium sulfate. Filter and concentrate under reduced pressure to obtain a yellow oil, add water (30 mL) and reflux at high temperature for 24 h. After the reaction is completed, concentrate under reduced pressure, wash the crude product with anhydrous ethanol, and obtain white flaky crystals of arecoline with a yield of 86%.

[0048] Step 2: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carbonyl chloride Place arecaline (0.917 g, 6.5 mmol) in a dry two-necked flask, add SOCl2 (5 mL), and heat to reflux. The reaction ends when the solid is completely dissolved. Remove the excess SOCl2 under reduced pressure to obtain a powdery white solid, which can be directly used for the next step without purification.

[0049] Step 3: Preparation of Compound Ⅰ-65 The compound prepared in step 2 (0.24 g, 1.5 mmol) was placed in anhydrous CH2Cl2, and triethylamine (0.3 mL, 2 mmol) and 3-phenoxybenzyl alcohol (0.300 g, 1.5 mmol) were added in turn under ice bath, and the mixture was reacted at room temperature for 0.5 h. After the reaction was completed, saturated NaHCO3 was added to quench the reaction, and the mixed solution was extracted with CH2Cl2 (3×20 mL), the organic phases were combined, washed with saturated brine, dried over anhydrous MgSO4, filtered, concentrated under reduced pressure, and purified by silica gel column chromatography (eluent: ethyl acetate) to obtain a yellow oily liquid with a yield of 70.4%.

[0050] The results of H NMR spectrum are: 1 H NMR (400 MHz, Chloroform- d ) δ 7.39 – 7.32 (m, 2H),7.30 – 7.23 (m, 0H), 7.14 – 7.03 (m, 2H), 7.02 – 6.96 (m, 2H),6.95 – 6.89 (m,1H), 6.88 – 6.83 (m, 1H), 6.74 (tt, J = 4.4, 1.0 Hz, 1H), 5.18 (t, J = 1.0 Hz,2H), 3.22 – 3.16 (m, 2H), 2.84 – 2.75 (m, 2H), 2.31 (s, 3H), 2.29 – 2.16 (m,2H).

[0051] Embodiment nine: The structural formula of the arecoline ester derivatives of this embodiment is shown in I-89 below: Its synthesis method is: Step 1: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid (arecaline) Dissolve 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid methyl ester-hydrobromide (arecoline hydrobromide) (2.35 g, 10 mmol) in water (30 mL) and adjust the pH value to 10-11 with 30% Na2CO3. Extract the mixed solution with CH2Cl2 (3×30 mL), combine the organic phases, wash with saturated brine, and dry over anhydrous magnesium sulfate. Filter and concentrate under reduced pressure to obtain a yellow oil, add water (30 mL) and reflux at high temperature for 24 h. After the reaction is completed, concentrate under reduced pressure, wash the crude product with anhydrous ethanol, and obtain white flaky crystals of arecoline with a yield of 86%.

[0052] Step 2: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carbonyl chloride Place arecaline (0.917 g, 6.5 mmol) in a dry two-necked flask, add SOCl2 (5 mL), and heat to reflux. The reaction ends when the solid is completely dissolved. Remove the excess SOCl2 under reduced pressure to obtain a powdery white solid, which can be directly used for the next step without purification.

[0053] Step 3: Preparation of Compound Ⅰ-89 The compound prepared in step 2 (0.24 g, 1.5 mmol) was placed in anhydrous CH2Cl2, and triethylamine (0.3 mL, 2 mmol) and 1,3,4-thiadiazole-2-methanol (0.174 g, 1.5 mmol) were added in turn under an ice bath, and the mixture was reacted at room temperature for 0.5 h. After the reaction was completed, saturated NaHCO3 was added to quench the reaction, and the mixed solution was extracted with CH2Cl2 (3×20 mL), the organic phases were combined, washed with saturated brine, dried over anhydrous MgSO4, filtered, concentrated under reduced pressure, and purified by silica gel column chromatography (eluent: ethyl acetate) to obtain a yellow oily liquid with a yield of 65.5%.

[0054] The results of H NMR spectrum are: 1 H NMR (400 MHz, Chloroform- d ) δ 8.88 (s, 1H), 6.77 –6.71 (m, 1H), 5.93 – 5.18 (m, 2H), 3.84 – 3.31 (m, 2H), 2.83 –2.74 (m, 2H),2.31 (s, 3H), 2.29 – 2.16 (m, 2H).

[0055] Embodiment ten: The structural formula of the arecoline ester derivatives of this embodiment is shown in I-100 below: Its synthesis method is: Step 1: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid (arecaline) Dissolve 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid methyl ester-hydrobromide (arecoline hydrobromide) (2.35 g, 10 mmol) in water (30 mL) and adjust the pH value to 10-11 with 30% Na2CO3. Extract the mixed solution with CH2Cl2 (3×30 mL), combine the organic phases, wash with saturated brine, and dry over anhydrous magnesium sulfate. Filter and concentrate under reduced pressure to obtain a yellow oil, add water (30 mL) and reflux at high temperature for 24 h. After the reaction is completed, concentrate under reduced pressure, wash the crude product with anhydrous ethanol, and obtain white flaky crystals of arecoline with a yield of 86%.

[0056] Step 2: Preparation of 1-methyl-1,2,5,6-tetrahydropyridine-3-carbonyl chloride Place arecaline (0.917 g, 6.5 mmol) in a dry two-necked flask, add SOCl2 (5 mL), and heat to reflux. The reaction ends when the solid is completely dissolved. Remove the excess SOCl2 under reduced pressure to obtain a powdery white solid, which can be directly used for the next step without purification.

[0057] Step 3: Preparation of Compound Ⅰ-100 The compound prepared in step 2 (0.24 g, 1.5 mmol) was placed in anhydrous CH2Cl2, and triethylamine (0.3 mL, 2 mmol) and 4-cyclopropylcyclohexane-1-ol (0.253 g, 1.5 mmol) were added in turn under an ice bath, and the mixture was reacted at room temperature for 0.5 h. After the reaction was completed, saturated NaHCO3 was added to quench the reaction, and the mixed solution was extracted with CH2Cl2 (3×20 mL), the organic phases were combined, washed with saturated brine, dried over anhydrous MgSO4, filtered, concentrated under reduced pressure, and purified by silica gel column chromatography (eluent: ethyl acetate) to obtain a yellow oily liquid with a yield of 66.3%.

[0058] The results of H NMR spectrum are: 1 H NMR (400 MHz, Chloroform- d ) δ 6.74 – 6.68 (m, 1H), 4.84 – 4.76 (m, 1H), 3.22 – 3.16 (m, 2H), 2.84 – 2.75 (m, 2H), 2.31 (s, 3H), 2.29 – 2.16 (m, 2H), 2.00 – 1.90 (m, 2H), 1.80 – 1.66 (m, 3H), 1.66 – 1.56 (m, 2H), 1.53 – 1.41 (m, 3H), 0.71 – 0.56 (m, 4H).

[0059] Other compounds described in the present invention can be prepared by the above method.

[0060] Table 1 shows the structures of some compounds (Ⅰ-1 to Ⅰ-101) after the structure of formula I is replaced by substituents. Specific application Application Example 1 Antibacterial biological activity assay: The experimental method adopts the mycelium growth rate method: The tested bacteria were rice blast pathogen ( Magnaporthe rice )、Mango stem rot fungus ( Botryodipladia theobromae ), Triticum aestivum ( Fusarium verticillium )、Apple ring rot fungus( Bothryosphaeria dothidea )、Mango Anthracnose( Colletotrichum gloeosporioides ), Rice Sheath Blight Pathogen ( Rhizoctonia solani )、Phomopsis spp. Diaporthe ambiguus )、Tea Polytrichomonas Pseudopestalotiopsis theae )、Phytophthora capsici ( Phytophthora capsicum ), provided by College of Tropical Agriculture and Forestry, Hainan University.

[0061] The test agent of the arecoline ester derivative of the present invention is prepared into a potato dextrose agar medium with a mass concentration of 100 mg / L. A 5 mm diameter puncher is used to take a bacterial cake, and it is inoculated on a potato dextrose agar medium containing the test agent, and a medium containing the same solvent and auxiliary agent is used as a control. Each group is repeated three times, and the growth of the colony is observed. When the diameter of the blank control colony grows to 2 / 3 of the whole dish, the colony diameter is measured vertically and crosswise to calculate the antibacterial rate.

[0062] Result processing Bacterial inhibition rate (%) = [(average colony diameter of the control group - average colony diameter of the treatment group) / (average colony diameter of the control group - diameter of the bacterial cake)] × 100%; According to the inhibition rate of plant pathogenic fungi, it is divided into five levels: 90≤A≤100%; 80≤B<90%; 70≤C<80%; 60≤D<70%; E<60%.

[0063] Table 2 Antibacterial activity test results of some compounds at 100 mg / L concentration It can be seen from the bioassay results in Table 2 that the arecoline ester derivatives provided by the present invention have good antibacterial activity against plant pathogenic fungi at a concentration of 100 mg / L, and the inhibition rate is greater than 60%. They can be used as active ingredients of chemical pesticides in the prevention and treatment of plant pathogens, and mixed with other carriers or adjuvants allowed in plant protection to prepare various dosage forms that can be used in agriculture.

[0064] Application Example 2 Insecticidal bioactivity assay: The test pest was Aedes aegypti ( Aedes aegypti ) Fourth instar larvae: The test agent of the arecoline ester derivative of the present invention is prepared into a dechlorinated aqueous solution with a mass concentration of 100 mg / L, and 30 4th instar larvae of Aedes aegypti are randomly selected and placed in a culture dish containing 10 mL of the drug solution, and dechlorinated water containing the same solvent and auxiliary agent is used as a control, and each group is repeated three times. When the drug solution is treated for 24 h and 48 h, the insect body is lightly touched with a needle, and the inability to move is regarded as death, and the dead larvae and the surviving larvae are counted to calculate the mortality rate.

[0065] Result processing: Mortality rate (%) = number of dead insects / total number of insects × 100%; Adjusted mortality (%) = [(treatment mortality - control mortality) / (1 - control mortality)] × 100%; According to the mortality rate to Aedes aegypti larvae, it is divided into five levels: 90≤A≤100%; 80≤B<90%; 70≤C<80%; 60≤D<70%; E<60%.

[0066] Table 3 Test results of insecticidal activity of some compounds against Aedes aegypti larvae at 100 mg / L It can be seen from the bioassay results in Table 3 that the arecoline ester derivatives provided by the present invention have good insecticidal activity against the fourth instar larvae of Aedes aegypti at a concentration of 100 mg / L, and the corrected mortality rate is greater than 60%. They can be used as active ingredients of chemical pesticides in the prevention and control of crop pests or mites, and mixed with other carriers or adjuvants allowed in plant protection to prepare various dosage forms that can be used in agriculture.

[0067] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. An arecoline ester derivative, characterized in that: Its structural formula is shown in formula (I): In formula (I): X is selected from S or O; m is 0, 1, 2 or 3; R is selected from R 1 is an aromatic ring containing a substituent, R 2 is an alicyclic ring containing a substituent, R 3 is an oxygen heterocycle containing a substituent, R 4 is a nitrogen heterocyclic ring containing a substituent, R 5 is a sulfur heterocycle containing a substituent, R 6 is a substituted aromatic heterocyclic ring, R 7 is a benzoheterocyclic ring containing a substituent, R 8 It is a polycyclic aromatic hydrocarbon containing substituents.

2. An arecoline ester derivative according to claim 1, characterized in that: In formula (I), R is selected from R 1 N 1 Substituted aromatic ring, R 2 N 2 Substituted alicyclic, R 3 N 3 Substituted oxygen heterocycle, R 4 N 4 Substituted nitrogen heterocycle, R 5 N 5 Substituted sulfur heterocycle, R 6 N 6 Substituted aromatic heterocycle, R 7 N 7 Substituted benzoheterocycle, R 8 N 8 Substituted polycyclic aromatic hydrocarbons.

3. An arecoline ester derivative according to claim 2, characterized in that: N 1 One or more selected from the group consisting of a hydrogen atom, a halogen atom, a cyano group, an amino group, a hydroxyl group, a C1-C6 alkyl group, a halogenated C1-C6 alkyl group, a C1-C6 alkoxy group, a halogenated C1-C6 alkoxy group, a C1-C6 alkylamino group, a halogenated C1-C6 alkylamino group, a di(C1-C6 alkyl)amino group, a halogenated di(C1-C6 alkyl)amino group, a C1-C6 alkoxycarbonyl group, a halogenated C1-C6 alkoxycarbonyl group, a C1-C6 alkylaminocarbonyl group, a halogenated C1-C6 alkylaminocarbonyl group, a di(C1-C6 alkyl)aminocarbonyl group, a halogenated di(C1-C6 alkyl)aminocarbonyl group, a C1-C6 alkylsulfonyl group, a halogenated C1-C6 alkylsulfonyl group, a di(C1-C6 alkyl)aminosulfonyl group, a halogenated di(C1-C6 alkyl)aminosulfonyl group, a C1-C6 alkylsulfonyloxy group, and a halogenated C1-C6 alkylsulfonyloxy group; N 2 One or more selected from the group consisting of a hydrogen atom, a halogen atom, a cyano group, an amino group, a hydroxyl group, a C1-C6 alkyl group, a halogenated C1-C6 alkyl group, a C3-C6 cycloalkyl group, a halogenated C3-C6 cycloalkyl group, a C2-C6 alkenyl group, a halogenated C2-C6 alkenyl group, a C2-C6 alkenyloxy group, a halogenated C2-C6 alkenyloxy group, a C1-C6 alkoxy group, a halogenated C1-C6 alkoxy group, a C1-C6 alkylamino group, a halogenated C1-C6 alkylamino group, a di(C1-C6 alkyl)amino group, a halogenated di(C1-C6 alkyl)amino group, a C1-C6 alkoxycarbonyl group, a halogenated C1-C6 alkoxycarbonyl group, a C1-C6 alkylaminocarbonyl group, a halogenated C1-C6 alkylaminocarbonyl group, a di(C1-C6 alkyl)aminocarbonyl group, and a halogenated di(C1-C6 alkyl)aminocarbonyl group; N 3 One or more selected from the group consisting of a hydrogen atom, a halogen atom, a cyano group, an amino group, a hydroxyl group, a C1-C6 alkyl group, a halogenated C1-C6 alkyl group, a C1-C6 alkoxy group, a halogenated C1-C6 alkoxy group, a C1-C6 alkylamino group, a halogenated C1-C6 alkylamino group, a di(C1-C6 alkyl)amino group, a halogenated di(C1-C6 alkyl)amino group, a C1-C6 alkoxycarbonyl group, a halogenated C1-C6 alkoxycarbonyl group, a C1-C6 alkylaminocarbonyl group, a halogenated C1-C6 alkylaminocarbonyl group, a di(C1-C6 alkyl)aminocarbonyl group, and a halogenated di(C1-C6 alkyl)aminocarbonyl group; N 4 One or more selected from the group consisting of a hydrogen atom, a halogen atom, a cyano group, an amino group, a hydroxyl group, a C1-C6 alkyl group, a halogenated C1-C6 alkyl group, a C1-C6 alkoxy group, a halogenated C1-C6 alkoxy group, a C1-C6 alkylamino group, a halogenated C1-C6 alkylamino group, a di(C1-C6 alkyl)amino group, a halogenated di(C1-C6 alkyl)amino group, a C1-C6 alkoxycarbonyl group, a halogenated C1-C6 alkoxycarbonyl group, a C1-C6 alkylaminocarbonyl group, a halogenated C1-C6 alkylaminocarbonyl group, a di(C1-C6 alkyl)aminocarbonyl group, and a halogenated di(C1-C6 alkyl)aminocarbonyl group; N 5 One or more selected from hydrogen atom, halogen atom, cyano group, amino group, hydroxyl group, C1-C6 alkyl group, halogenated C1-C6 alkyl group, C1-C6 alkoxy group, halogenated C1-C6 alkoxy group, C1-C6 alkylamino group, halogenated C1-C6 alkylamino group, di(C1-C6 alkyl)amino group, halogenated di(C1-C6 alkyl)amino group, C1-C6 alkoxycarbonyl group, halogenated C1-C6 alkoxycarbonyl group, C1-C6 alkylaminocarbonyl group, halogenated C1-C6 alkylaminocarbonyl group, di(C1-C6 alkyl)aminocarbonyl group, halogenated di(C1-C6 alkyl)aminocarbonyl group, C1-C6 alkylthio group, halogenated C1-C6 alkylthio group, C1-C6 alkenylthio group and halogenated C1-C6 alkenylthio group; N 6 One or more selected from the group consisting of a hydrogen atom, a halogen atom, a cyano group, an amino group, a hydroxyl group, a C1-C6 alkyl group, a halogenated C1-C6 alkyl group, a C1-C6 alkoxy group, a halogenated C1-C6 alkoxy group, a C1-C6 alkylamino group, a halogenated C1-C6 alkylamino group, a di(C1-C6 alkyl)amino group, a halogenated di(C1-C6 alkyl)amino group, a C1-C6 alkoxycarbonyl group, a halogenated C1-C6 alkoxycarbonyl group, a C1-C6 alkylaminocarbonyl group, a halogenated C1-C6 alkylaminocarbonyl group, a di(C1-C6 alkyl)aminocarbonyl group, and a halogenated di(C1-C6 alkyl)aminocarbonyl group; N 7 One or more selected from the group consisting of a hydrogen atom, a halogen atom, a cyano group, an amino group, a hydroxyl group, a C1-C6 alkyl group, a halogenated C1-C6 alkyl group, a C1-C6 alkoxy group, a halogenated C1-C6 alkoxy group, a C1-C6 alkylamino group, a halogenated C1-C6 alkylamino group, a di(C1-C6 alkyl)amino group, a halogenated di(C1-C6 alkyl)amino group, a C1-C6 alkoxycarbonyl group, a halogenated C1-C6 alkoxycarbonyl group, a C1-C6 alkylaminocarbonyl group, a halogenated C1-C6 alkylaminocarbonyl group, a di(C1-C6 alkyl)aminocarbonyl group, and a halogenated di(C1-C6 alkyl)aminocarbonyl group; N 8 One or more selected from a hydrogen atom, a halogen atom, a cyano group, an amino group, a hydroxyl group, a C1-C6 alkyl group, a halogenated C1-C6 alkyl group, a C1-C6 alkoxy group, a halogenated C1-C6 alkoxy group, a C1-C6 alkylamino group, a halogenated C1-C6 alkylamino group, a di(C1-C6 alkyl)amino group, a halogenated di(C1-C6 alkyl)amino group, a C1-C6 alkoxycarbonyl group, a halogenated C1-C6 alkoxycarbonyl group, a C1-C6 alkylaminocarbonyl group, a halogenated C1-C6 alkylaminocarbonyl group, a di(C1-C6 alkyl)aminocarbonyl group and a halogenated di(C1-C6 alkyl)aminocarbonyl group.

4. The method for preparing the arecoline ester derivatives according to any one of claims 1 to 3, characterized in that: The compounds represented by general formula II, III and IV are reacted to obtain the product. The specific reaction steps include: S1. Put the compound of formula II and thionyl chloride into a round-bottom flask under anhydrous conditions, reflux until the solid is completely dissolved, remove the excess thionyl chloride to obtain a white solid compound of formula III, and directly proceed to the next step without purification; S2. React the compound of formula III, an acid-binding agent, a compound of formula IV and an organic solvent at -5 to 50°C and monitor the reaction by TLC. After the reaction is completed, extract, concentrate and purify by silica gel column chromatography to obtain a compound of formula I.

5. The method for preparing the arecoline ester derivatives according to claim 4, characterized in that: The acid binding agent is one or more of triethylamine, pyridine, N,N-diisopropylethylamine, 1-methylpyridine, sodium acetate, potassium carbonate, and sodium hydroxide; the organic solvent is one or more of dichloromethane, chloroform, carbon tetrachloride, ethyl acetate, acetonitrile, N,N-dimethylformamide, dimethyl sulfoxide, methanol, ethanol, petroleum ether, n-butanol, benzene, toluene, xylene, ether, and tetrahydrofuran.

6. The use of the arecoline ester derivatives according to any one of claims 1 to 3, characterized in that: The arecoline ester derivatives are used in fungicidal compositions and insecticidal compositions.

7. The use of the arecoline ester derivatives according to claim 6, characterized in that: The bactericidal composition comprises at least one of the arecoline ester derivatives and is used as an agricultural bactericide. The mass fraction of the arecoline ester derivative in the bactericidal composition is 1 to 99.9%.

8. The use of the arecoline ester derivatives according to claim 7, characterized in that: The dosage form of the agricultural fungicide is at least one of emulsifiable concentrate, water emulsion, microemulsion, wettable powder, water dispersible granules and suspension, and the agricultural fungicide is used for preventing and controlling plant pathogenic fungi.

9. The use of the arecoline ester derivatives according to claim 6, characterized in that: The insecticide composition comprises at least one of the arecoline ester derivatives and is used as an agricultural insecticide. The mass fraction of the arecoline ester derivative in the insecticide composition is 1 to 99.9%.

10. The use of the arecoline ester derivatives according to claim 9, characterized in that: The dosage form of the agricultural pesticide is at least one of emulsifiable concentrate, water emulsion, microemulsion, wettable powder, water dispersible granule and suspension, and the agricultural pesticide is used to control pests or mites.

Citation Information

Patent Citations

  • Sterilizing compound and application thereof in pesticides

    CN106719822A

  • Preparation method of amino acid bonded arecoline derivative

    CN116987062A

  • Compound insecticide for preventing and treating thrips of passion fruits

    CN118177202A

  • Use of pyridinium salts for protecting plants against infestation by micro-organisms

    EP0493671A1

  • Tetrahydropyridine carboxylic acid esters and salts thereof and their use as insecticidal and acaricidal agents

    GB1468644A

Cited By

  • Areca-arecoline hydrazide compound, preparation thereof and application of arecoline hydrazide compound in preparation of anti-inflammatory drugs

    CN121895219A

  • A arecoline hydrazide compound and preparation and application thereof in preparation of anti-inflammatory drugs

    CN121895219B